Come up with a name for your new list and we'll add to it:
Hepregen raised a round of funding on January 18, 2010. Investors include
National Science Foundation.
Hepregen, a spinout of MIT, is developing a platform to reduce the liver toxicity caused by approved drugs. The platform is based on technology developed by Sangeeta Bhatia, an associate professor in …